147 related articles for article (PubMed ID: 38488992)
21. Knockdown of MTHFD2 inhibits proliferation and migration of nasopharyngeal carcinoma cells through the ERK signaling pathway.
Wu S; Cai W; Shi Z; Ming X; Yang X; Zhou Y; Chen X; Yang M
Biochem Biophys Res Commun; 2022 Jul; 614():47-55. PubMed ID: 35567943
[TBL] [Abstract][Full Text] [Related]
22. Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer.
Zhang H; Zhu S; Zhou H; Li R; Xia X; Xiong H
Front Oncol; 2023; 13():1098357. PubMed ID: 36726381
[TBL] [Abstract][Full Text] [Related]
23. Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2).
Lee LC; Peng YH; Chang HH; Hsu T; Lu CT; Huang CH; Hsueh CC; Kung FC; Kuo CC; Jiaang WT; Wu SY
J Med Chem; 2021 Aug; 64(15):11288-11301. PubMed ID: 34337952
[TBL] [Abstract][Full Text] [Related]
24. High Expression of Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) in Esophageal Squamous Cell Carcinoma and its Clinical Prognostic Significance.
He H; Li PC; Jia W; Hu B; Ji CS
Med Sci Monit; 2020 Feb; 26():e920259. PubMed ID: 32088725
[TBL] [Abstract][Full Text] [Related]
25. MTHFD2, metabolic mastermind of CD4
Gouirand V; Rosenblum MD
Sci Immunol; 2022 Mar; 7(69):eabo6765. PubMed ID: 35245088
[TBL] [Abstract][Full Text] [Related]
26. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
27. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
Shang M; Yang H; Yang R; Chen T; Fu Y; Li Y; Fang X; Zhang K; Zhang J; Li H; Cao X; Gu J; Xiao J; Zhang Q; Liu X; Yu Q; Wang T
Nat Commun; 2021 Mar; 12(1):1940. PubMed ID: 33782411
[TBL] [Abstract][Full Text] [Related]
28. Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastoma.
Zhu Z; Kiang KM; Li N; Liu J; Zhang P; Jin L; He X; Zhang S; Leung GK
Cancer Lett; 2022 Nov; 549():215903. PubMed ID: 36089117
[TBL] [Abstract][Full Text] [Related]
29. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
[TBL] [Abstract][Full Text] [Related]
30. Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells.
Hitzel J; Lee E; Zhang Y; Bibli SI; Li X; Zukunft S; Pflüger B; Hu J; Schürmann C; Vasconez AE; Oo JA; Kratzer A; Kumar S; Rezende F; Josipovic I; Thomas D; Giral H; Schreiber Y; Geisslinger G; Fork C; Yang X; Sigala F; Romanoski CE; Kroll J; Jo H; Landmesser U; Lusis AJ; Namgaladze D; Fleming I; Leisegang MS; Zhu J; Brandes RP
Nat Commun; 2018 Jun; 9(1):2292. PubMed ID: 29895827
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor suppressor by targeting MTHFD2.
Li SM; Zhao YQ; Hao YL; Liang YY
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1203-1213. PubMed ID: 30779090
[TBL] [Abstract][Full Text] [Related]
32. A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer.
Lee J; Chen X; Wang Y; Nishimura T; Li M; Ishikawa S; Daikoku T; Kawai J; Tojo A; Gotoh N
Biochem Biophys Res Commun; 2021 Dec; 584():7-14. PubMed ID: 34753066
[TBL] [Abstract][Full Text] [Related]
33. Deacetylation of MTHFD2 by SIRT4 senses stress signal to inhibit cancer cell growth by remodeling folate metabolism.
Zhang F; Wang D; Li J; Su Y; Liu S; Lei QY; Yin M
J Mol Cell Biol; 2022 Jul; 14(4):. PubMed ID: 35349697
[TBL] [Abstract][Full Text] [Related]
34. Glioma cells require one-carbon metabolism to survive glutamine starvation.
Tanaka K; Sasayama T; Nagashima H; Irino Y; Takahashi M; Izumi Y; Uno T; Satoh N; Kitta A; Kyotani K; Fujita Y; Hashiguchi M; Nakai T; Kohta M; Uozumi Y; Shinohara M; Hosoda K; Bamba T; Kohmura E
Acta Neuropathol Commun; 2021 Jan; 9(1):16. PubMed ID: 33468252
[TBL] [Abstract][Full Text] [Related]
35. Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma.
Liu X; Huang Y; Jiang C; Ou H; Guo B; Liao H; Li X; Yang D
Dig Liver Dis; 2016 Aug; 48(8):953-60. PubMed ID: 27257051
[TBL] [Abstract][Full Text] [Related]
36. HRD1 functions as a tumor suppressor in ovarian cancer by facilitating ubiquitination-dependent SLC7A11 degradation.
Wang Y; Wang S; Zhang W
Cell Cycle; 2023 May; 22(9):1116-1126. PubMed ID: 36809917
[TBL] [Abstract][Full Text] [Related]
37. Suppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion.
Koufaris C; Gallage S; Yang T; Lau CH; Valbuena GN; Keun HC
J Proteome Res; 2016 Aug; 15(8):2618-25. PubMed ID: 27315223
[TBL] [Abstract][Full Text] [Related]
38. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
39. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer.
Nilsson R; Jain M; Madhusudhan N; Sheppard NG; Strittmatter L; Kampf C; Huang J; Asplund A; Mootha VK
Nat Commun; 2014; 5():3128. PubMed ID: 24451681
[TBL] [Abstract][Full Text] [Related]
40. MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma.
Green NH; Galvan DL; Badal SS; Chang BH; LeBleu VS; Long J; Jonasch E; Danesh FR
Oncogene; 2019 Aug; 38(34):6211-6225. PubMed ID: 31289360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
